Triple

T6070079
Position Surface form Disambiguated ID Type / Status
Subject HMPC E135258 entity
Predicate worksWith P398 FINISHED
Object Committee for Medicinal Products for Human Use E139009 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Committee for Medicinal Products for Human Use | Statement: [HMPC, worksWith, Committee for Medicinal Products for Human Use]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Committee for Medicinal Products for Human Use
Context triple: [HMPC, worksWith, Committee for Medicinal Products for Human Use]
  • A. Committee for Medicinal Products for Human Use chosen
    The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.
  • B. Committee for Herbal Medicinal Products
    The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
  • C. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • D. European Medicines Agency
    The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
  • E. Committee for Orphan Medicinal Products
    The Committee for Orphan Medicinal Products is a specialized expert body that evaluates and advises on the designation and development of medicines for rare diseases within the European Union.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c00879e8048190b690717d19c5bc03 completed March 22, 2026, 3:19 p.m.
NER Named-entity recognition batch_69c05742867481908e3f45c875807c73 completed March 22, 2026, 8:55 p.m.
NED1 Entity disambiguation (via context triple) batch_69c20d4e28b48190bb44675c5c035bd3 completed March 24, 2026, 4:04 a.m.
Created at: March 22, 2026, 4:10 p.m.